• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病中的高钾血症:患病率及相关性。

Hyperkalaemia in diabetes: prevalence and associations.

作者信息

Jarman P R, Kehely A M, Mather H M

机构信息

Ealing Hospital, Southall, Middlesex, UK.

出版信息

Postgrad Med J. 1995 Sep;71(839):551-2. doi: 10.1136/pgmj.71.839.551.

DOI:10.1136/pgmj.71.839.551
PMID:7479468
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2398240/
Abstract

Hyperkalaemia is associated with diabetes, but there are no recent reports of its prevalence and associations. Serum potassium concentrations were measured in all 1764 patients attending a diabetic clinic over a 12-month period and found to be > 5.0 mmol/l in 270 (15%), and > 5.4 mmol/l in 67 (4%). There was no other evident cause of hyperkalaemia in 41 of these 67 patients. These data serve to highlight the risk of dangerous hyperkalaemia in diabetic patients, particularly with concurrent administration of angiotensin-converting-enzyme inhibitors and potassium-sparing diuretics.

摘要

高钾血症与糖尿病相关,但近期尚无关于其患病率及关联因素的报道。在为期12个月的时间里,对一家糖尿病诊所的1764例患者均进行了血清钾浓度检测,结果发现,270例(15%)患者的血清钾浓度>5.0 mmol/L,67例(4%)患者的血清钾浓度>5.4 mmol/L。在这67例患者中,有41例未发现其他明显的高钾血症病因。这些数据凸显了糖尿病患者发生危险的高钾血症的风险,尤其是在同时使用血管紧张素转换酶抑制剂和保钾利尿剂的情况下。

相似文献

1
Hyperkalaemia in diabetes: prevalence and associations.糖尿病中的高钾血症:患病率及相关性。
Postgrad Med J. 1995 Sep;71(839):551-2. doi: 10.1136/pgmj.71.839.551.
2
Risk factors associated with a high velocity of the development of hyperkalaemia in hospitalised patients.住院患者高钾血症快速发展的相关危险因素。
Drug Saf. 2007;30(1):71-80. doi: 10.2165/00002018-200730010-00007.
3
Hyperkalaemia in people with diabetes: occurrence, risk factors and outcomes in a Danish population-based cohort study.丹麦基于人群的队列研究中糖尿病患者高钾血症的发生、危险因素和结局。
Diabet Med. 2018 Aug;35(8):1051-1060. doi: 10.1111/dme.13687. Epub 2018 Jun 1.
4
[Risk for hyperkalemia during long-term treatment with angiotensin-converting enzyme inhibitors in insulin-dependent type 2 diabetics in relation to the glomerular filtration rate].胰岛素依赖型2型糖尿病患者长期使用血管紧张素转换酶抑制剂治疗期间高钾血症风险与肾小球滤过率的关系
Dtsch Med Wochenschr. 2001 Nov 23;126(47):1327-30. doi: 10.1055/s-2001-18569.
5
Life-threatening hyperkalaemia caused by ACE inhibitor and diuretics.
Diabet Med. 1997 Sep;14(9):808. doi: 10.1002/(SICI)1096-9136(199709)14:9<808::AID-DIA464>3.0.CO;2-2.
6
No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients.肾素-血管紧张素系统阻滞剂导致的高钾血症对维持性血液透析患者无影响。
Nephrol Dial Transplant. 2007 Apr;22(4):1150-5. doi: 10.1093/ndt/gfl752. Epub 2007 Jan 25.
7
Prevalence and factors associated with false hyperkalaemia in Asians in primary care: a cross-sectional study (the Unlysed Hyperkalaemia- the Unseen Burden (UHUB) study).在初级保健中,亚洲人群中假性高钾血症的流行情况及相关因素:一项横断面研究(未分析的高钾血症-未被重视的负担(UHUB)研究)。
BMJ Open. 2020 Sep 22;10(9):e033755. doi: 10.1136/bmjopen-2019-033755.
8
Hypertension, hyperkalaemia and abnormalities of the renin-angiotensin system in diabetes mellitus.
Ir J Med Sci. 1979;148 Suppl 2:17-27. doi: 10.1007/BF02938136.
9
Onset time of hyperkalaemia after angiotensin receptor blocker initiation: when should we start serum potassium monitoring?血管紧张素受体阻滞剂起始后高钾血症的发作时间:我们何时应开始监测血清钾?
J Clin Pharm Ther. 2014 Feb;39(1):61-8. doi: 10.1111/jcpt.12109. Epub 2013 Nov 22.
10
Prevalence of Hyperkalemia in Diabetic and Non-Diabetic Patients with Chronic Kidney Disease: A Nested Case-Control Study.糖尿病和非糖尿病慢性肾脏病患者高钾血症的患病率:一项巢式病例对照研究
Am J Nephrol. 2015;42(5):351-60. doi: 10.1159/000442393. Epub 2015 Nov 25.

引用本文的文献

1
New Treatment Options for Hyperkalemia in Patients with Chronic Kidney Disease.慢性肾脏病患者高钾血症的新治疗选择
J Clin Med. 2020 Jul 22;9(8):2337. doi: 10.3390/jcm9082337.
2
Hyperkalemia in ambulant postcardiac surgery patients during combined therapy with angiotensin-converting enzyme inhibitor, spironolactone, and diet rich in potassium: A report of two cases and review of literature.心脏手术后门诊患者在联合使用血管紧张素转换酶抑制剂、螺内酯及高钾饮食治疗期间出现高钾血症:两例报告并文献复习
Ann Card Anaesth. 2019 Apr-Jun;22(2):162-168. doi: 10.4103/aca.ACA_65_18.
3
Mineralocorticoid receptor antagonists for heart failure: a real-life observational study.醛固酮受体拮抗剂治疗心力衰竭:一项真实世界观察性研究。
ESC Heart Fail. 2018 Jun;5(3):267-274. doi: 10.1002/ehf2.12244. Epub 2018 Feb 4.
4
How to Improve Adherence to Life-saving Heart Failure Treatments with Potassium Binders.如何通过钾结合剂提高对挽救生命的心力衰竭治疗的依从性。
Card Fail Rev. 2017 Apr;3(1):33-39. doi: 10.15420/cfr.2017.2.1.
5
Compared effects of calcium and sodium polystyrene sulfonate on mineral and bone metabolism and volume overload in pre-dialysis patients with hyperkalemia.比较钙和聚苯乙烯磺酸钠对高钾血症透析前患者矿物质和骨代谢以及容量超负荷的影响。
Clin Exp Nephrol. 2018 Feb;22(1):35-44. doi: 10.1007/s10157-017-1412-y. Epub 2017 Apr 18.
6
Effect of the SGLT2 Inhibitor Dapagliflozin on Potassium Levels in Patients with Type 2 Diabetes Mellitus: A Pooled Analysis.钠-葡萄糖协同转运蛋白2抑制剂达格列净对2型糖尿病患者血钾水平的影响:一项汇总分析
Diabetes Ther. 2016 Mar;7(1):125-37. doi: 10.1007/s13300-015-0150-y. Epub 2016 Jan 12.
7
Risk of hyperkalemia in patients with moderate chronic kidney disease initiating angiotensin converting enzyme inhibitors or angiotensin receptor blockers: a randomized study.中度慢性肾脏病患者起始使用血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂时高钾血症的风险:一项随机研究。
BMC Res Notes. 2013 Aug 1;6:306. doi: 10.1186/1756-0500-6-306.
8
Diabetes may be independent risk factor for hyperkalaemia.糖尿病可能是高钾血症的独立危险因素。
BMJ. 2003 Oct 4;327(7418):812. doi: 10.1136/bmj.327.7418.812.
9
Effect of diabetes on serum potassium concentrations in acute coronary syndromes.糖尿病对急性冠状动脉综合征患者血清钾浓度的影响。
Heart. 2003 Jan;89(1):31-5. doi: 10.1136/heart.89.1.31.
10
Hospital-acquired hyperkalaemia.医院获得性高钾血症。
Postgrad Med J. 1997 Jul;73(861):433-4. doi: 10.1136/pgmj.73.861.433.

本文引用的文献

1
Effect of acute hyperglycaemia on plasma potassium and aldosterone levels in type 2 (non-insulin-dependent) diabetes.急性高血糖对2型(非胰岛素依赖型)糖尿病患者血浆钾和醛固酮水平的影响
Diabetologia. 1982 Mar;22(3):184-7. doi: 10.1007/BF00283750.
2
Hyporeninemic hypoaldosteronism. An overlooked cause of hyperkalemia.低肾素性低醛固酮血症。高钾血症的一个被忽视的原因。
Arch Intern Med. 1981 Jan;141(1):30-3. doi: 10.1001/archinte.141.1.30.
3
Hyperkalemia and hyporeninemic hypoaldosteronism.高钾血症与低肾素性低醛固酮血症
Kidney Int. 1980 Jan;17(1):118-34. doi: 10.1038/ki.1980.14.
4
Hyperkalaemia in diabetes mellitus--potential hazards of coexisting hyporeninaemic hypoaldosteronism.糖尿病中的高钾血症——并存低肾素性低醛固酮血症的潜在危害。
Postgrad Med J. 1984 May;60(703):370-3. doi: 10.1136/pgmj.60.703.370.
5
Effect of hyperglycemia on plasma sodium and potassium concentration revisited.
Clin Chem. 1991 Feb;37(2):293-4.
6
Reduction of erythrocyte (Na(+)-K+) ATPase activities in non-insulin-dependent diabetic patients with hyperkalemia.高钾血症的非胰岛素依赖型糖尿病患者红细胞(钠 - 钾)ATP酶活性降低。
Metabolism. 1992 Apr;41(4):426-30. doi: 10.1016/0026-0495(92)90079-p.
7
Paradoxical glucose-induced hyperkalemia. Combined aldosterone-insulin deficiency.反常性葡萄糖诱导的高钾血症。醛固酮-胰岛素联合缺乏。
Am J Med. 1975 Nov;59(5):744-50. doi: 10.1016/0002-9343(75)90236-3.
8
Nonuremic diabetic hyperkalemia. Possible role of insulin deficiency.
Arch Intern Med. 1977 Jul;137(7):842-3. doi: 10.1001/archinte.137.7.842.
9
Aldosterone responsiveness in patients with diabetes mellitus.
Diabetes. 1978 Jul;27(7):732-7. doi: 10.2337/diab.27.7.732.